Nanox (NNOX) received additional information requests from FDA related to single-source version of Nanox.ARC

Go back to Nanox (NNOX) received additional information requests from FDA related to single-source version of Nanox.ARC

Nano-X Imaging (NNOX) PT Lowered to $67 at Cantor Fitzgerald

February 1, 2021 10:07 AM EST

Cantor Fitzgerald analyst Steven Halper lowered the price target on Nano-X Imaging (NASDAQ: NNOX) to $67.00 (from $70.00) while maintaining an Overweight rating.

The analyst commented, "We reiterate our Overweight rating and lower our price target to $67 from $70. On Monday, February 1, NNOX filed a 6-K... More